Cancer ca 19 9 antigen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Cell Line T-Lymphocytes Cell Line, Tumor Tumor Cells, Cultured Cells, Cultured CA1 Region, Hippocampal Immune Sera CA3 Region, Hippocampal B-Lymphocytes Lymph Nodes Neoplastic Stem Cells Prostate Cell Membrane Dendritic Cells Lymphocytes T-Lymphocytes, Cytotoxic Breast Spleen Sarcoplasmic Reticulum Antigen-Presenting Cells CD8-Positive T-Lymphocytes

Organisms7

Mice, Inbred BALB C Mice, Nude Mice, Inbred C57BL Rabbits Mice, Transgenic Mice, SCID Simian virus 40

Diseases36

Prostatic Neoplasms Ovarian Neoplasms Colonic Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Disease Progression Carcinoma, Squamous Cell Colorectal Neoplasms Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma Cell Transformation, Neoplastic Rectal Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Endometrial Neoplasms Liver Neoplasms Melanoma Esophageal Neoplasms Disease Models, Animal Carcinoma, Small Cell Neoplasms, Hormone-Dependent Mouth Neoplasms Head and Neck Neoplasms Skin Neoplasms Bone Neoplasms Neoplasms, Experimental Neoplasms, Radiation-Induced Precancerous Conditions

Chemicals and Drugs96

Antigens Antigens, Bacterial Antigens, Neoplasm Antigens, Surface Antigens, Viral Antigens, Protozoan Antigens, Polyomavirus Transforming HLA Antigens Antigens, CD Carcinoembryonic Antigen Prostate-Specific Antigen Antigens, Fungal Antibodies, Monoclonal Antigens, Helminth H-2 Antigens Antigens, Viral, Tumor Cancer Vaccines Antigens, Tumor-Associated, Carbohydrate Proliferating Cell Nuclear Antigen Receptors, Antigen, T-Cell HLA-DR Antigens Neoplasm Proteins Histocompatibility Antigens Epitopes Histocompatibility Antigens Class II Receptors, Antigen, B-Cell O Antigens RNA, Messenger HLA-A2 Antigen Antigens, CD15 Tumor Markers, Biological Antigens, CD8 Immunoglobulin G Antigens, CD3 Ca(2+) Mg(2+)-ATPase HLA-A Antigens Blood Group Antigens Antineoplastic Agents Hepatitis B Surface Antigens Histocompatibility Antigens Class I CA-125 Antigen Receptors, Antigen Receptors, Estrogen Calcium Antigens, CD45 HLA-D Antigens Antigens, CD4 Hepatitis B Antigens Recombinant Proteins CA-19-9 Antigen Immune Sera Antigens, CD1 DNA, Neoplasm Antibodies, Bacterial Antigens, Differentiation Ki-67 Antigen RNA, Small Interfering Receptor, erbB-2 Tumor Suppressor Protein p53 HLA-B Antigens Antibodies Membrane Proteins Peptides MART-1 Antigen Calcium-Transporting ATPases Antigens, CD80 Fluorouracil Tamoxifen HIV Antigens Antineoplastic Agents, Hormonal Enzyme Inhibitors Receptors, Progesterone Epstein-Barr Virus Nuclear Antigens Antineoplastic Agents, Phytogenic Antigens, CD19 Autoantigens DNA-Binding Proteins Nuclear Proteins Cisplatin Antigens, Heterophile Glycoproteins Membrane Glycoproteins Antigens, CD40 DNA Primers Interferon-gamma Antigen-Antibody Complex Hepatitis B Core Antigens Anticarcinogenic Agents Antigens, Thy-1 Recombinant Fusion Proteins Thapsigargin Immunoglobulin M Forssman Antigen Egtazic Acid Paclitaxel Transcription Factors

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Early Detection of Cancer Enzyme-Linked Immunosorbent Assay Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Sensitivity and Specificity Immunoenzyme Techniques Prognosis Survival Analysis Fluorescent Antibody Technique Survival Rate Flow Cytometry Lymphocyte Activation Retrospective Studies Follow-Up Studies Gene Expression Profiling Transfection Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Risk Prospective Studies Polymerase Chain Reaction Neoplasm Staging Xenograft Model Antitumor Assays Immunohistochemistry Registries Risk Assessment Disease-Free Survival Immunization Models, Biological Transplantation, Heterologous Combined Modality Therapy Odds Ratio Immunoblotting Chemotherapy, Adjuvant Risk Factors Oligonucleotide Array Sequence Analysis Predictive Value of Tests Multivariate Analysis Disease Models, Animal Reproducibility of Results Kaplan-Meier Estimate Tumor Burden Clinical Trials as Topic Mammography Drug Screening Assays, Antitumor Questionnaires Electrophoresis, Polyacrylamide Gel Immunodiffusion Molecular Targeted Therapy SEER Program Neoplasms, Experimental

Psychiatry and Psychology1

Phenomena and Processes42

Gene Expression Regulation, Neoplastic Mutation Amino Acid Sequence Sensitivity and Specificity Base Sequence Genetic Predisposition to Disease Cross Reactions Antibody Specificity Lymphocyte Activation Transfection Drug Resistance, Neoplasm Cell Division Risk Dose-Response Relationship, Drug Time Factors Signal Transduction Cell Survival Antigen-Antibody Reactions Antibody Formation Down-Regulation Genotype Phenotype Cell Proliferation Cell Movement Gene Expression Phosphorylation Apoptosis Odds Ratio Protein Binding DNA Methylation Promoter Regions, Genetic Polymorphism, Genetic Up-Regulation Molecular Weight Cell Cycle Genes, BRCA1 RNA Interference Alleles Cell Growth Processes Cell Differentiation Immunity, Cellular Gene Silencing

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science7

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate Registries Questionnaires SEER Program

Named Groups1

Health Care22

Sensitivity and Specificity Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Risk Prospective Studies National Cancer Institute (U.S.)Registries Age Factors Risk Assessment Disease-Free Survival Immunization Odds Ratio Risk Factors Predictive Value of Tests Multivariate Analysis Reproducibility of Results Kaplan-Meier Estimate Clinical Trials as Topic Questionnaires SEER Program

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Antigens Antigens, Bacterial Antigens, Neoplasm Antigens, Surface Antigens, Viral Early Detection of Cancer Antigens, Protozoan Antigens, Polyomavirus Transforming HLA Antigens Antigens, CD Carcinoembryonic Antigen Prostatic Neoplasms Prostate-Specific Antigen Antigens, Fungal Antibodies, Monoclonal Antigens, Helminth H-2 Antigens Ovarian Neoplasms Colonic Neoplasms Breast Neoplasms Lung Neoplasms Antigens, Viral, Tumor Cancer Vaccines Antigens, Tumor-Associated, Carbohydrate Molecular Sequence Data Stomach Neoplasms Proliferating Cell Nuclear Antigen Receptors, Antigen, T-Cell HLA-DR Antigens Neoplasms Neoplasm Metastasis Mice, Inbred BALB C Neoplasm Proteins Enzyme-Linked Immunosorbent Assay Histocompatibility Antigens Neoplasm Invasiveness Mice, Nude Pancreatic Neoplasms Cell Line Epitopes Gene Expression Regulation, Neoplastic Histocompatibility Antigens Class II T-Lymphocytes Receptors, Antigen, B-Cell O Antigens Blotting, Western RNA, Messenger Mutation Amino Acid Sequence HLA-A2 Antigen Antigens, CD15 Reverse Transcriptase Polymerase Chain Reaction Cell Line, Tumor Sensitivity and Specificity Tumor Markers, Biological Immunoenzyme Techniques Base Sequence Antigens, CD8 Prognosis Survival Analysis Immunoglobulin G Fluorescent Antibody Technique Uterine Cervical Neoplasms Antigens, CD3 Genetic Predisposition to Disease Ca(2+) Mg(2+)-ATPase Survival Rate HLA-A Antigens Flow Cytometry Blood Group Antigens Cross Reactions Antineoplastic Agents Disease Progression Hepatitis B Surface Antigens Carcinoma, Squamous Cell Antibody Specificity Lymphocyte Activation Mice, Inbred C57BL Histocompatibility Antigens Class I Colorectal Neoplasms Retrospective Studies Urinary Bladder Neoplasms Tumor Cells, Cultured Follow-Up Studies Gene Expression Profiling Transfection Drug Resistance, Neoplasm Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Cell Division Carcinoma, Non-Small-Cell Lung Risk Prospective Studies Polymerase Chain Reaction Dose-Response Relationship, Drug Carcinoma Neoplasm Staging National Cancer Institute (U.S.)Cells, Cultured CA-125 Antigen

No FAQ available that match "cancer ca 19 9 antigen"